SiMoA Quanterix Posts Large Drop in Reagent Sales as Restructuring Effort Tackles Quality Control Premium The company reported a 4 percent decline in Q3 revenues and a 30 percent drop in consumables revenue while addressing issues with assay quality control. Quanterix, WuXi AppTec to Open Joint Lab in Shanghai The lab will provide researchers in the Asia-Pacific region with access to Quanterix's Simoa technology and biomarker testing, development, and validation services. Inventor of Quanterix Tech Exploring Point-of-Care Simoa Device for Tuberculosis Detection Premium In a study published this week, researchers presented a Simoa-based assay for tuberculosis that could ultimately be packaged as a point-of-care test. Quanterix Raises $49.7 in Stock Offering The company sold 2.2 million shares at an average price of $22.73 per share under a $50 million at-the-market equity facility it filed in March 2019. Quanterix Q1 Revenues Up 64 Percent The company posted Q1 revenues of $12.3 million, up from $7.5 million in Q1 2018 and above the consensus Wall Street estimate of $10.2 million. Jul 18, 2017 Quanterix, Partners Develop PCR-Free miRNA Detection Method for Liver Toxicity Testing Premium Aug 7, 2015 New Study Describes Development of Simoa Assays for C. Diff Toxin Detection Premium Feb 20, 2015 Researchers Develop Simoa-based Assay for Dengue Fever Host Immune Response Mar 21, 2014 JAMA Neurology Study Uses Quanterix's Simoa Platform to Assess Hockey-related Brain Injury Premium Jan 23, 2014 Quanterix, Banyan Biomarkers among Winners of Research Awards for GE, NFL 'Head Health Challenge' Sep 3, 2013 Swedish Researchers Adopt Quanterix Arrays to Identify Concussion Biomarkers in Hockey Players Premium Aug 9, 2013 Quanterix Launches RUO Simoa Platform with 18 Initial Assays and Homebrew Kit Premium Aug 2, 2013 New Products: Quanterix Launches Simoa Instrument and More Premium Nov 27, 2012 BioMerieux Invests $15M in Quanterix, Will Use SiMoA to Support PSA and Infectious Disease Assays Premium Jul 24, 2012 Quanterix Building Commercial Team Ahead of Planned 2013 Launch for Simoa Platform Premium Feb 10, 2012 Forsyth Wins Gates Foundation Grant for TB Biomarker Work on Quanterix's SiMoA System Premium Jan 10, 2012 In-Q-Tel Backs Quanterix to Expand Pathogen Detection for Defense Applications Premium Jan 6, 2012 With Backing from In-Q-Tel, Quanterix Continues Move into Pathogen Detection, Defense Applications Premium Oct 21, 2011 Quanterix's AccuPSA Test Predicts Five-Year Recurrence-Free Survival in Prostate Cancer Study Premium Aug 16, 2011 Quanterix, Stratec Partner on Tool for Life Sciences, IVD Jun 3, 2011 Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade Premium Feb 25, 2011 Shifting Focus From Dx Development, Quanterix Aims to Launch Commercial SiMoA Instrument in 2013 Premium Nov 2, 2010 Quanterix Wins $733K QTDP Grant to Develop Array-Based Prostate Cancer Test Premium Jun 11, 2010 Study Shows Quanterix's Single Molecule Array Assay Measures PSA at Previously Undetectable Levels Premium Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.